# Pfizer Inc. (PFE) — Q4-2024 Earnings Results

**Report date:** 2025-02-04 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q4-2024

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 1.26%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.63 | N/A | +30.98% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in their product pipeline and operational strategies. They acknowledged market challenges but remain focused on long-term growth.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They emphasized ongoing commitment to innovation and pipeline development.

> There was a focus on maintaining operational efficiency amid market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report shows a strong EPS performance, exceeding expectations significantly. However, the stock reacted negatively, declining by 1.26%. This could indicate investor concerns about revenue performance or broader market conditions, despite the positive EPS surprise.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q4-2024_